Autologous Tumour Vaccine Trial
NCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 06219941 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 06120283 Brief Summary This is a dose escalation and dose expansion…
Read more arrow_forwardNCT 05523947 Brief Summary This first-in-human study will be counducted to evaluate…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 07110584 Brief Summary This study is designed to characterize the safety,…
Read more arrow_forwardNCT 05598151 Brief Summary This is a Phase1 study to assess the…
Read more arrow_forwardNCT 06926075 Brief Summary This clinical trial is an adaptive study of…
Read more arrow_forwardNCT 06923761 Brief Summary This is a Phase I/II, open-label, first-in human…
Read more arrow_forwardNCT 05647122 Brief Summary This is a first-in-human (FIH) Phase I, multi-center,…
Read more arrow_forward